On Saturday, in the city of Charlottesville, Virginia, reports depicted a violent scene, in which white supremacists - and those demonstrating against them - threw fists, wielded sticks and shields and left each other bruised, bloodied and battered.
On Saturday, President Xi Jinping asked relevant authorities to make maximum efforts to reduce casualties and prevent secondary disasters. Premier Li Ke?qiang also gave instructions to the rescue work.
On Friday, US President Donald Trump ordered the US forces to launch missile strikes on targets in Syria for Syria's alleged use of chemical weapons against civilians in the country.
On Friday, European Union technology commissioner Andrus Ansip said the bloc should worry about Huawei and other Chinese technology companies because of the risk to EU industry and security.
On Jan 14, Wang visited the fever clinic at the Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology.
On May 27 last year, Xiongan New Area appeared for the first time in a report reviewed at a Political Bureau meeting of the CPC Central Committee.
上海排名seo公司
On Jan 17, Tianjin Museum announced a new special exhibition: "Ancient Civilization of the Andes Illuminating the Origins of the Inca Empire." Unfortunately the museum is currently closed due to the coronavirus outbreak, but its online version is attracting a growing audience. Yang Cheng / China Daily
On Friday, the State Department said Pompeo and Afghan President Ashraf Ghani agreed in a phone call to "accelerate efforts" to end the war and said the United States was committed to a conditions-based drawdown of troops.
On Monday, health minister instructed health departments of cities and provinces nationwide to intensify early detection and rapid containment of dengue fever outbreaks. The localities were asked to launch big campaigns on killing mosquito larvae, and to well treat dengue fever patients.
On March 13, Fosun Pharma became the strategic partner of BioNTech in China, jointly developing and commercializing vaccine products for COVID-19 based on its proprietary mRNA technology platform in China. Apart from discussing the research and development plans with partners and completing clinical trials in China, Fosun Pharma has also designed and completed animal challenge trials of selected mRNA vaccines, including BNT162b2, in collaboration with Chinese research institutes, and shared outcomes with partners in a timely manner.